Back to search
Renal Allograft Recipients
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Renal Allograft Recipients trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Renal Allograft Recipients trials you may qualify forChronic Allograft Nephropathy (CAN)/Interstitial fibrosis and Tubular Atrophy (IFTA) is responsible for most kidney transplant failures. CAN/IFTA on a 3 month k…
This study is designed to investigate a novel approach to offer more ESRD participants the benefits associated with renal transplantation by increasing the supp…
The purpose of this study is to evaluate the benefits and risks of conversion of existing adolescent kidney allograft recipients aged 12 to less than 18 years o…
This clinical study aims to investigate a new, non-invasive method for monitoring kidney function after transplantation. Currently, assessing the health of a tr…
The aim of the study is to assess prevalence of frailty among renal transplant recipients in Alexandria University Hospitals and to study the relation between f…
This clinical trial investigates whether 18 months of daily SGLT2i (10 mg Forxiga) preserves kidney function and evaluates safety, based on eGFR changes and adv…
This randomized, open-label, single-center clinical trial aims to evaluate the effect of dapagliflozin on kidney allograft function in adult recipients of a fir…
Endothelial lesions within the transplanted kidney are a major determinant of chronic allograft nephropathy. Epoxyeicosatrienoic acids (EETs) are endothelium-de…